SCHEMBL14008331

SCHEMBL14008331

CCOC(=O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(OCC(C)=O)ccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.48
ALDH1A1 P00352 9/20 0.48
RAB9A P51151 5/20 0.48
NPC1 O15118 4/20 0.48
KMT2A Q03164 3/20 0.48
STAT1 P42224 1/20 0.48
HPGD P15428 7/20 0.48
USP2 O75604 3/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
HSD17B10 Q99714 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ABCB1 P08183 1/20 0.45
CFTR P13569 1/20 0.44
PAX8 Q06710 1/20 0.44
ATM Q13315 1/20 0.44
GOPC Q9HD26 1/20 0.44
MAPT P10636 3/20 0.43
LMNA P02545 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14008329 0.93 KDM4E (0.50) KDM4EALDH1A1RAB9ANPC1KMT2A
SCHEMBL28520428 0.93 ABCB1 (0.48) KDM4EALDH1A1KMT2AHPGDUSP2
SCHEMBL14035116 0.92 KDM4E (0.50) KDM4EALDH1A1RAB9ANPC1KMT2A
SCHEMBL14008335 0.91 KDM4E (0.51) KDM4EALDH1A1RAB9AKMT2AHPGD
SCHEMBL14035115 0.89 KDM4E (0.51) KDM4EALDH1A1KMT2AHPGDUSP2
SCHEMBL21974831 0.88 ABCB1 (0.44) KDM4EALDH1A1KMT2AHPGDUSP2
SCHEMBL10205410 0.85 ABCB1 (0.48) KDM4EALDH1A1KMT2AUSP2HSD17B10
SCHEMBL24855342 0.83 USP2 (0.47) KDM4EALDH1A1RAB9ANPC1KMT2A
SCHEMBL14527749 0.83 USP2 (0.55) KDM4EALDH1A1RAB9AKMT2AUSP2
SCHEMBL1104941 0.81 USP2 (0.49) RAB9ANPC1KMT2AUSP2ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275215-A1 Fluorescein-Based Compounds And Their Use For Peptide Synthesis COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275215-A1 Fluorescein-Based Compounds And Their Use For Peptide Synthesis DNPEP, ANPEP, PEPD KDM4E 4808/4885ALDH1A1 3716/4885RAB9A 2855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.